Carrie Brownstein

Director, Shattuck Labs, Inc.

Companies

Shattuck Labs, Inc.Board member Nov 17, 2021 to now¹
Zentalis Pharmaceuticals, Inc.Chief Medical Officer Oct 3, 2022 to Oct 6, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zentalis Pharmaceuticals, Inc. ZNTL105,685 shares³$236.2K at $2.23Oct 4, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 4, 2023Sold 1,722 shares at $19.91 of Zentalis Pharmaceuticals, Inc.³
Oct 4, 2023Sold 8,906 shares at $19.43 of Zentalis Pharmaceuticals, Inc.³
Feb 1, 2023Granted 16,313 shares of Zentalis Pharmaceuticals, Inc.⁴
Oct 3, 2022Granted 100,000 shares of Zentalis Pharmaceuticals, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARShattuck Labs, Inc., Board member
2
SEC EDGARZentalis Pharmaceuticals, Inc., Chief Medical Officer
3
SEC EDGARZentalis Pharmaceuticals, Inc. shares after the filing of Oct 4, 2023
4
SEC EDGARForm 4 filed Feb 1, 2023
5
SEC EDGARForm 4 filed Oct 3, 2022